Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
06/2005
06/16/2005CA2542941A1 Analysis of mass spectral data in the quiet zones and label selection therefor
06/15/2005EP1541564A1 Five-membered heterocyclic compounds
06/15/2005EP1541339A1 Multilayer acrylate film with improved optical and mechanical properties
06/15/2005EP1539772A1 Process of making phosphordiamidite compounds
06/15/2005EP1539763A1 Azaindole kinase inhibitors
06/15/2005EP1539729A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/15/2005EP1539688A2 Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
06/15/2005EP1539674A1 Amino-propanol derivatives
06/15/2005EP1539672A1 Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
06/15/2005EP1539666A1 Method for producing dialdehydes and/or ethylenically unsaturated monoaldehydes by hydroformylating ethylenically unsaturated compounds
06/15/2005EP1448576B1 Preparation of crystalline polymorphs of fosinopril sodium
06/15/2005EP1448574B1 Phosphorus-borates with low melting points
06/15/2005EP1341797A4 Ortho substituted chiral phosphines and phosphinites and their use in asymmetric catayltic reactions
06/15/2005EP1334108B1 ARYL PHOSPHATE DERIVATIVES OF d4T
06/15/2005EP1222194B1 7-acylamino-3-heteroarylthio-3-cephem carboxylic acid antibiotics and prodrugs thereof
06/15/2005CN1628122A Process for producing tertiary phosphine having bulky hydrocarbon group bonded
06/15/2005CN1628121A Continuous process for preparing n-phosphonomethyl glycine
06/15/2005CN1627990A Method for hydroformylation using catalyst of xanthene-bridged ligands
06/15/2005CN1627962A Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts
06/15/2005CN1627939A Bicyclic CB2 cannabinoid receptor ligands
06/15/2005CN1626558A Catalysts for olefin polymerization
06/15/2005CN1626539A Method for preparing lecithin in high purity
06/15/2005CN1626538A Phosphorylated glyceryl ether aluminium salts
06/15/2005CN1206247C Method of polymerization
06/15/2005CN1206233C Synthesis and use of novelthorium color developing reagent metafluoro azo fluorophosphine
06/15/2005CN1206231C 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
06/15/2005CN1206204C Complex compound containing acidic functional group and method of preparing adipic acid/adipate using said complex compound
06/15/2005CN1205937C Phosphatidic acid-comprising compositions
06/14/2005US6906230 Method for producing alcohol surfactants and alcohol ether surfactants, the products obtained and their use
06/14/2005US6906218 Nitrile functionalized; catalytic hydrocyanation of 1-2-4-trivinylcyclohexane
06/14/2005US6906217 Tertiary carbocyclic amines used as charge transfer compounds or light emitter layers for flat panel displays
06/14/2005US6906213 Forming asymmetric reaction catalysts; reacting phosphine linked secondary amine with phosphorous trihalide in inert organic solvent containing acid acceptor; combining inter-mediate with alkali or alkaline earth organometallic
06/14/2005US6906212 Phosphine-phosphoramidite compounds
06/14/2005US6906058 Prevent bile acid transportation; anticholesterol agents
06/14/2005US6906055 Bactericides; antibiotiucs; dissolving in water, crystallization; Ceftaroline fosamil acetate
06/14/2005US6906007 Insecticides, miticides
06/14/2005US6906006 Applying to plants, environment
06/14/2005US6905999 Coordination polymerization catalyst
06/14/2005CA2304967C 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/14/2005CA2247172C Novel 1(2h) quinoline carboxylic acid derivatives, method for preparing same, and use thereof for synthesising substances having antibiotic properties
06/14/2005CA2219687C Stabilizer combination for the rotomolding process
06/14/2005CA2098842C Use of host cell phospholipids for inhibiting microbial colonization
06/12/2005CA2490733A1 Multi-layer acrylic film with improved optical and mechanical properties
06/09/2005WO2005051964A1 Method for asymmetric synthesis
06/09/2005WO2005051963A1 Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same
06/09/2005WO2005051351A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
06/09/2005WO2005051298A2 Novel phosphorus-containing thyromimetics
06/09/2005WO2005039552A3 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives
06/09/2005WO2005012313A3 Aldolase-inhibiting aromatic compounds
06/09/2005WO2005003777A3 Enzyme-catalyzed metal deposition for the enhanced in situ detection of immunohistochemical epitopes and nucleic acid sequences
06/09/2005US20050124830 Non-C2-symmetric bisphosphine ligands as catalysts for asymmetric hydrogenation
06/09/2005US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
06/09/2005US20050124771 Olefin polymerization catalysts, transition metal compounds, processes for olefin polymerization, and alpha-olefin/conjugated diene copolymers
06/09/2005US20050124621 Novel inhibitors of kinases
06/09/2005US20050124619 Medical devices employing triazine compounds and compositions thereof
06/09/2005US20050124588 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
06/09/2005US20050124587 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
06/09/2005US20050124586 Alpha-substituted arylalkyl phosphonate derivatives
06/09/2005US20050124585 Which contain phosphoramidate linkages; for retroviral or hepadnaviral therapy; for treatment of HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability
06/09/2005US20050124584 Prodrugs of phosphonate nucleotide analogues
06/09/2005US20050124583 Prodrugs of phosphonate nucleotide analogues
06/09/2005US20050124582 2-amino-6-substituted-9-[(2-hydroxymethyl or phosphatomethyl)cyclopropylidenemethyl]purines; herpes viruses, cytomegalo virus, Epstein-Barr virus, HIV
06/09/2005US20050124581 Alpha-substituted heteroarylalkyl phosphonate derivatives
06/09/2005US20050124024 contacting the solubilized p-nitrophenyl phosphate with charcoal, a buffered solution of phenyl phosphate can be provided with super stability
06/09/2005US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions
06/09/2005US20050123566 Immunomodulatory compounds and methods of use thereof
06/09/2005US20050123533 Prodrugs activated by targeted catalytic proteins
06/09/2005CA2546616A1 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification
06/09/2005CA2546601A1 Novel phosphorus-containing thyromimetics
06/08/2005EP1537160A1 Curing agents for epoxy resins, use thereof and epoxy resin cured therewith
06/08/2005EP1537130A1 Carboxylic acid derivatives containing phosphorous groups and organically polymerisable groups
06/08/2005EP1537129A1 Akt inhibitors, pharmaceutical compositions, and uses thereof
06/08/2005EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers
06/08/2005EP1536776A2 Derivatives of 1,3-cyclic propanediol phosphate and their action as cell stimulants
06/08/2005EP1536686A1 Sodium glyphosate compositions and process for their preparation
06/08/2005EP1483274B1 Improved method for the production of bisphosphites
06/08/2005EP1252133B1 Pharmaceutical compounds
06/08/2005EP1102775B1 Novel phospholipids with unsaturated alkyl and acyl chains
06/08/2005CN1205215C Oxime derivatives and the use thereof as latent acids
06/08/2005CN1205151C Halogenation of protected phenols in meta position
06/07/2005US6903182 Contacting at least one acrylic monomer under polymerization conditions with a catalyst containing a copper chloride (CuCl) complexed with a ligand containing mono or bicyclic phosphours ring
06/07/2005US6903118 Piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
06/07/2005US6903081 Phosphoramidates and methods therefor
06/07/2005US6903080 Disease treatment with novel phospholipid derivatives
06/07/2005US6903043 Chiral polymeric salen catalyst, and a process for preparing chiral compounds from racemic epoxides by using them
06/07/2005US6902608 Hydrolysis-resistant phosphonic acids with ethylenically unsaturated double bonds; suitable for use as adhesion promoters
06/07/2005CA2263204C Process for producing mercaptoalkanesulfonates and phosphonates and derivatives thereof
06/02/2005WO2005050206A2 Competitive immunoassay
06/02/2005WO2005049849A2 Fluorescence quenching azo dyes, their methods of preparation and use
06/02/2005WO2005049722A1 Flame retardant containing organophosphorous compound, its preparation process, and flame retardant resin composition comprising same
06/02/2005WO2005049629A1 Process for preparing bisphospholane ligands
06/02/2005WO2005049628A1 Method for the production of mono(fluoroalkyl)phosphoranes, bis(fluoroalkyl)phosphoranes, and the corresponding acids and phosphates
06/02/2005WO2005049627A1 Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
06/02/2005WO2005049555A1 Method for the production of organic salts containing bis(perfluoroalkyl)phosphinate anions
06/02/2005WO2005048715A2 Organophosphoric compounds and use thereof
06/02/2005US20050119516 Trimerization of ethylene with a catalyst system comprising a coordination catalyst of a chromium source complexed with a di(alkylphosphinoalkyl)amino ligand, and an alumoxane; improved catalyst selectivity
06/02/2005US20050119513 Treated with a strong organic base selected from potassium tert-butoxide, n-butyllithium,a metal amide or a Grignard reagent before or during the reaction; perfluoroalkylation agents with improved stability
06/02/2005US20050119495 For use as catalysts in asymmetric reactions, such as, hydrogenation, hydride transfer, allylic alkylation, hydrosilylation, hydroboration, hydrovinylation, hydroformylation, olefin metathesis, hydrocarboxylation
06/02/2005US20050119429 Catalysts for olefin polymerization
06/02/2005US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor
1 ... 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 ... 554